Bed Bath & Beyond (BBBY) elevates Marcus Lemonis to CEO as COO departs

Rhea-AI Filing Summary

Bed Bath & Beyond, Inc. reported a leadership change at the top of the company. The Board appointed Marcus Lemonis, currently Executive Chairman and the company’s principal executive officer, as Chief Executive Officer, effective January 1, 2026. He will continue to serve as Executive Chairman and principal executive officer, consolidating the company’s senior leadership roles under one individual. The company plans to enter into an employment agreement with Mr. Lemonis, with key terms to be disclosed in a later filing.

The company also ended the employment of Alexander Thomas, its Chief Operating Officer and principal operating officer, as of the same effective date. Mr. Thomas is expected to act as an advisor for a transition period after January 1, 2026 to support an orderly handover of his responsibilities.

Insights

Corporate governance and leadership analyst

CEO role shifts to Marcus Lemonis while COO exits, concentrating leadership.

Bed Bath & Beyond, Inc. is consolidating senior leadership by appointing Marcus Lemonis, already Executive Chairman and principal executive officer, as Chief Executive Officer effective January 1, 2026. He retains his existing positions, so oversight of strategy and day-to-day executive authority will be centered in a single individual.

The employment of Alexander Thomas, Chief Operating Officer and principal operating officer, ended on the same effective date, with his continued involvement only as an advisor for a transition period. This indicates a planned handover rather than an abrupt break, which may help maintain operational continuity while the new leadership structure takes hold.

The company also notes it intends to finalize an employment agreement with Mr. Lemonis, with material terms to be detailed in a future disclosure. Subsequent filings may provide clarity on his compensation structure and any specific performance incentives that could shape strategic priorities.

false0001130713NYSENYSE00011307132025-12-302025-12-300001130713us-gaap:CommonStockMember2025-12-302025-12-300001130713byon:WarrantsToPurchaseSharesOfCommonStockMember2025-12-302025-12-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

December 30, 2025

Date of Report (date of earliest event reported)

Bed Bath & Beyond, Inc.

(Exact name of Registrant as specified in its charter)

Delaware	000-41850	87-0634302
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

433 W. Ascension Way, 3rd Floor

Murray, Utah 84123

(Address of principal executive offices)(Zip Code)

(801) 947-3100

(Registrant’s telephone number, including area code)

Beyond, Inc.

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		BBBY		New York Stock Exchange
Warrants to Purchase Shares of Common Stock		BBBY WS		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 30, 2025, the Board of Directors (the “Board”) of Bed Bath & Beyond, Inc. (the “Company”) appointed Marcus Lemonis, Executive Chairman of the Board and the Company’s principal executive officer, as the Company’s Chief Executive Officer, effective as of January 1, 2026 (the “Effective Date”). Mr. Lemonis will continue in his roles as Executive Chairman of the Board and the Company’s principal executive officer.  The Company intends to enter into an employment agreement with Mr. Lemonis, the material terms of which will be disclosed in a subsequent filing, once finalized.

A description of each of the items required to be disclosed by Item 5.02(c)(2) of Form 8-K can be found in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 28, 2025, and is incorporated by reference herein.

Additionally, the employment of Alexander Thomas, the Company’s Chief Operating Officer and principal operating officer, was terminated on the Effective Date.  Mr. Thomas is anticipated to serve as an advisor to the Company for a transition period following the Effective Date to ensure the smooth transition of his duties.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BED BATH & BEYOND, INC.
By:	/s/ ADRIANNE B. LEE
	Adrianne B. Lee
	President and Chief Financial Officer
Date:	January 5, 2026

FAQ

Who was appointed CEO of Bed Bath & Beyond, Inc. (BBBY)?

Marcus Lemonis was appointed as the Chief Executive Officer of Bed Bath & Beyond, Inc. He already serves as Executive Chairman of the Board and the company’s principal executive officer and will continue in those roles.

When does Marcus Lemonis become CEO of Bed Bath & Beyond, Inc. (BBBY)?

The appointment of Marcus Lemonis as Chief Executive Officer is effective as of January 1, 2026, referred to as the Effective Date.

Will Marcus Lemonis keep his other roles at Bed Bath & Beyond, Inc. (BBBY)?

Yes. Marcus Lemonis will remain Executive Chairman of the Board and the company’s principal executive officer while also serving as Chief Executive Officer after the Effective Date.

What is happening with Alexander Thomas at Bed Bath & Beyond, Inc. (BBBY)?

The employment of Alexander Thomas, the company’s Chief Operating Officer and principal operating officer, was terminated as of the Effective Date. He is expected to serve as an advisor to the company for a transition period to support a smooth transfer of his duties.

Will Bed Bath & Beyond, Inc. (BBBY) sign a new employment agreement with Marcus Lemonis?

The company states that it intends to enter into an employment agreement with Marcus Lemonis. The material terms will be disclosed in a later filing once the agreement is finalized.

Where can investors find more background on Marcus Lemonis’s role at Bed Bath & Beyond, Inc. (BBBY)?

The company indicates that information required under Item 5.02(c)(2) can be found in its definitive proxy statement filed on March 28, 2025, which is incorporated by reference.